Entrada Therapeutics Inc (TRDA)
17.74
+0.14
(+0.82%)
USD |
NASDAQ |
Nov 04, 16:00
17.76
+0.01
(+0.06%)
After-Hours: 20:00
Entrada Therapeutics Market Cap: 660.11M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 654.71M |
| October 31, 2024 | 637.60M |
| October 30, 2024 | 640.95M |
| October 29, 2024 | 642.81M |
| October 28, 2024 | 646.16M |
| October 25, 2024 | 632.02M |
| October 24, 2024 | 626.44M |
| October 23, 2024 | 631.28M |
| October 22, 2024 | 637.23M |
| October 21, 2024 | 644.30M |
| October 18, 2024 | 648.76M |
| October 17, 2024 | 655.83M |
| October 16, 2024 | 656.94M |
| October 15, 2024 | 652.11M |
| October 14, 2024 | 663.27M |
| October 11, 2024 | 624.21M |
| October 10, 2024 | 588.13M |
| October 09, 2024 | 601.52M |
| October 08, 2024 | 609.70M |
| October 07, 2024 | 615.28M |
| October 04, 2024 | 635.00M |
| October 03, 2024 | 611.56M |
| October 02, 2024 | 605.98M |
| October 01, 2024 | 595.19M |
| September 30, 2024 | 594.45M |
| Date | Value |
|---|---|
| September 27, 2024 | 611.93M |
| September 26, 2024 | 586.64M |
| September 25, 2024 | 559.85M |
| September 24, 2024 | 572.87M |
| September 23, 2024 | 542.00M |
| September 20, 2024 | 546.09M |
| September 19, 2024 | 557.99M |
| September 18, 2024 | 507.77M |
| September 17, 2024 | 526.75M |
| September 16, 2024 | 541.25M |
| September 13, 2024 | 557.99M |
| September 12, 2024 | 552.79M |
| September 11, 2024 | 552.79M |
| September 10, 2024 | 547.58M |
| September 09, 2024 | 559.11M |
| September 06, 2024 | 550.55M |
| September 05, 2024 | 572.50M |
| September 04, 2024 | 572.87M |
| September 03, 2024 | 582.17M |
| August 30, 2024 | 658.43M |
| August 29, 2024 | 650.99M |
| August 28, 2024 | 607.10M |
| August 27, 2024 | 621.23M |
| August 26, 2024 | 629.05M |
| August 23, 2024 | 614.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.20M
Minimum
May 09 2022
1.094B
Maximum
Nov 17 2021
475.78M
Average
478.13M
Median
Market Cap Benchmarks
| Fulcrum Therapeutics Inc | 203.74M |
| Sarepta Therapeutics Inc | 11.74B |
| Catalyst Pharmaceuticals Inc | 2.581B |
| Vertex Pharmaceuticals Inc | 122.14B |
| Regenxbio Inc | 433.44M |
Market Cap Related Metrics
| PE Ratio | 5.995 |
| PS Ratio | 2.566 |
| Price to Book Value | 1.535 |
| Price | 17.74 |
| Earnings Yield | 16.68% |
| Operating PE Ratio | 6.572 |
| Normalized PE Ratio | 5.995 |